Global Anti-Obesity Devices Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023
Global Anti-Obesity Devices Market:
Global anti-obesity devices market estimated to be valued US$ XX Mn in 2017 and poised to grow at CAGR of XX% over 2017-2023. Market for anti-obesity devices is projected to reach US$ XX Mn by 2023.
Obesity is a medical condition that can be defined as abnormal or excessive fat accumulation, which may have the negative effect on health. According to World Health Organisation, a person with BMI of 30 or more is generally considered as obese. Obesity increases the chances of diseases like chronic diseases, including diabetes, cardiovascular diseases, osteoarthritis, and certain types of cancers. Obesity mainly caused by excessive food intake, lack of physical, exercise, genetic inheritance, and rarely it occurs due to endocrine disorders, medications, and mental disorders. U.S. Food and Drug Administration approved the anti-obesity devices for the treatment of obesity. Obesity can be overcome by changing the diet conditions, and physical activities.
The global anti-obesity devices, expected to grow at a significant CAGR due to increase in the prevalence of obesity. According to WHO, obesity has doubled since 2015. In 2014 around 13% of adults aged 18 years or above were obese, and cause of death of approximately 2.8 Mn people annually around the globe. Rising demand for less invasive procedures for obesity treatment has significantly affected the growth of anti-obesity devices market. Similarly, increase in disposable income in developing countries, and recent product approvals from U.S. Food and Drug Administration for new anti-obesity devices are the major factors boosting the growth of anti-obesity devices market. However, the side effects associated with the use of these devices, availability of medications for obesity, and product failure in some cases might hamper the growth of anti-obesity devices market over the forecast period.
Anti-obesity treatment market segmented on the basis of product type, method of deployment, and end user
Based on product-type, anti-obesity devices market has been segmented into the following:
Geographically, the anti-obesity devices market has been segmented into following regions Viz. North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. North America dominates the markets followed by Europe and Asia-Pacific. North American region is witnessed significant growth owing to the rise in a number of obese patients, according to American Heart Association, 70% American adults are obese or overweight. Moreover, according to the WHO in the European region, in 2012, about 50% of adults are suffering from obesity, which plays a key role in the global anti-obesity devices market growth. The Asia Pacific region is a key market for global anti-obesity devices due to the increase in obese patients, improving healthcare expenditure, and higher investments in healthcare which is expected to fuel the market for anti-obesity devices in Asia Pacific region.
Some of the players in anti-obesity devices market are Allergan, Inc. (U.S.), Medtronic. (Covidien PLC) (U.S.), EnteroMedics, Inc (U.S.), Cousin Biotech (France), Surgical IOC (Peters Surgical SAS) (France), PARE Surgical Inc. (U.S.), and GI Dynamics (U.S.) to name a few
In January 2017, GI Dynamics Inc.’s EndoBarrier receives German NUB reimbursement status 1 for type 2 diabetes and obesity therapy
REPORT OUTLINE:
Global anti-obesity devices market estimated to be valued US$ XX Mn in 2017 and poised to grow at CAGR of XX% over 2017-2023. Market for anti-obesity devices is projected to reach US$ XX Mn by 2023.
Obesity is a medical condition that can be defined as abnormal or excessive fat accumulation, which may have the negative effect on health. According to World Health Organisation, a person with BMI of 30 or more is generally considered as obese. Obesity increases the chances of diseases like chronic diseases, including diabetes, cardiovascular diseases, osteoarthritis, and certain types of cancers. Obesity mainly caused by excessive food intake, lack of physical, exercise, genetic inheritance, and rarely it occurs due to endocrine disorders, medications, and mental disorders. U.S. Food and Drug Administration approved the anti-obesity devices for the treatment of obesity. Obesity can be overcome by changing the diet conditions, and physical activities.
The global anti-obesity devices, expected to grow at a significant CAGR due to increase in the prevalence of obesity. According to WHO, obesity has doubled since 2015. In 2014 around 13% of adults aged 18 years or above were obese, and cause of death of approximately 2.8 Mn people annually around the globe. Rising demand for less invasive procedures for obesity treatment has significantly affected the growth of anti-obesity devices market. Similarly, increase in disposable income in developing countries, and recent product approvals from U.S. Food and Drug Administration for new anti-obesity devices are the major factors boosting the growth of anti-obesity devices market. However, the side effects associated with the use of these devices, availability of medications for obesity, and product failure in some cases might hamper the growth of anti-obesity devices market over the forecast period.
Anti-obesity treatment market segmented on the basis of product type, method of deployment, and end user
Based on product-type, anti-obesity devices market has been segmented into the following:
- Gastric bands
- Electrical stimulation system
- Gastric balloon system
- Gastric emptying system
- Appetite suppressors
- Trans-oral
- Endoscopy
- Surgery
- Hospitals
- Gastroenterology clinics
- Ambulatory surgical centers
Geographically, the anti-obesity devices market has been segmented into following regions Viz. North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. North America dominates the markets followed by Europe and Asia-Pacific. North American region is witnessed significant growth owing to the rise in a number of obese patients, according to American Heart Association, 70% American adults are obese or overweight. Moreover, according to the WHO in the European region, in 2012, about 50% of adults are suffering from obesity, which plays a key role in the global anti-obesity devices market growth. The Asia Pacific region is a key market for global anti-obesity devices due to the increase in obese patients, improving healthcare expenditure, and higher investments in healthcare which is expected to fuel the market for anti-obesity devices in Asia Pacific region.
Some of the players in anti-obesity devices market are Allergan, Inc. (U.S.), Medtronic. (Covidien PLC) (U.S.), EnteroMedics, Inc (U.S.), Cousin Biotech (France), Surgical IOC (Peters Surgical SAS) (France), PARE Surgical Inc. (U.S.), and GI Dynamics (U.S.) to name a few
In January 2017, GI Dynamics Inc.’s EndoBarrier receives German NUB reimbursement status 1 for type 2 diabetes and obesity therapy
REPORT OUTLINE:
- The report provides granular level information about the market size, regional market share and forecast from 2017-2023
- The report covers in-detail insights about the competitor’s overview, key findings and their key strategies
- The Report Outlines drivers, restraints, challenges, and trends that are currently faced by the industry
- The report tracks recent innovations, key developments and startup’s details that are working in the industry
- The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
1. EXECUTIVE SUMMARY
2. GLOBAL ANTI-OBESITY DEVICES MARKET INTRODUCTION
2.1. Global Anti-Obesity Devices Market– Taxonomy
2.2. Global Anti-Obesity Devices Market–Definitions
2.2.1. Product Type
2.2.2. End User
3. GLOBAL ANTI-OBESITY DEVICES MARKET DYNAMICS
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Anti-Obesity Devices Market Dynamics – Factors Impact Analysis
3.6. Global Anti-Obesity Devices Market– Regulations
3.6.1. U.S
3.6.2. Europe
3.6.3. Japan
3.7. Global Anti-Obesity Devices Market– Recent Product Launches
4. GLOBAL ANTI-OBESITY DEVICES MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023
4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Oppurtunity Analysis
5. GLOBAL ANTI-OBESITY DEVICES MARKET, BY PRODUCT TYPE, 2012 - 2016 AND FORECAST, 2017 - 2023
5.1. Gastric Bands
5.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Electrical Stimulation System
5.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Gastric Balloon System
5.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
5.4. Gastric Emptying System
5.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.3. Market Opportunity Analysis
5.5. Appetite Suppressors
5.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.5.3. Market Opportunity Analysis
6. GLOBAL ANTI-OBESITY DEVICES MARKET FORECAST, BY METHOD OF DEPLOYMENT, 2012 - 2016 AND FORECAST, 2017 - 2023
6.1. Trans-oral
6.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Endoscopy
6.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Surgery
6.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
7. GLOBAL ANTI-OBESITY DEVICES MARKET FORECAST, BY END USER, 2012 - 2016 AND FORECAST, 2017 - 2023
7.1. Hospitals
7.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Gastroenterology Clinics
7.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Ambulatory surgical centers
7.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
8. GLOBAL ANTI-OBESITY DEVICES MARKET FORECAST, BY REGION, 2012 - 2016 AND FORECAST, 2017 - 2023
8.1. North America
8.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Europe
8.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Asia-Pacific
8.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
8.4. Latin America
8.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.4.3. Market Opportunity Analysis
8.5. Middle East and Africa
8.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.5.3. Market Opportunity Analysis
8.6. Global Anti-Obesity Devices Market- Opportunity Analysis Index - By Product Type, By Method of Deployment, By End User, and Region, 2017 – 2023
9. NORTH AMERICA ANTI-OBESITY DEVICES MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
9.1.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.1.1.1. Gastric Bands
9.1.1.2. Electrical Stimulation System
9.1.1.3. Gastric Balloon System
9.1.1.4. Gastric Emptying System
9.1.1.5. Appetite Suppressors
9.1.2. Method of Deployment Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
9.1.2.1. Trans-oral
9.1.2.2. Endoscopy
9.1.2.3. Surgery
9.1.3. End User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
9.1.3.1. Hospitals
9.1.3.2. Gastroenterology clinics
9.1.3.3. Ambulatory surgical centers
9.1.4. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
9.1.4.1. U.S.
9.1.4.2. Canada
9.1.5. North America Anti-Obesity Devices Market- Opportunity Analysis Index - By Product Type, By Method of Deployment, By End User, and Country, 2017 – 2023
9.1.6. North America Anti-Obesity Devices Market Dynamics – Trends
10. EUROPE ANTI-OBESITY DEVICES MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
10.1.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1.1. Gastric Bands
10.1.1.2. Electrical Stimulation System
10.1.1.3. Gastric Balloon System
10.1.1.4. Gastric Emptying System
10.1.1.5. Appetite Suppressors
10.1.2. Method of Deployment Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.1.2.1. Trans-oral
10.1.2.2. Endoscopy
10.1.2.3. Surgery
10.1.3. End User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.1.3.1. Hospitals
10.1.3.2. Gastroenterology clinics
10.1.3.3. Ambulatory surgical centers
10.1.4. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.1.4.1. Germany
10.1.4.2. UK
10.1.4.3. France
10.1.4.4. Spain
10.1.4.5. Italy
10.1.4.6. Russia
10.1.4.7. Poland
10.1.4.8. Rest of Europe
10.1.5. Europe Anti-Obesity Devices Market- Opportunity Analysis Index - By Product Type, By Method of Deployment, By End User, and Country, 2017 – 2023
10.1.6. Europe Anti-Obesity Devices Market Dynamics – Trends
11. ASIA-PACIFIC ANTI-OBESITY DEVICES MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
11.1.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1.1. Gastric Bands
11.1.1.2. Electrical Stimulation System
11.1.1.3. Gastric Balloon System
11.1.1.4. Gastric Emptying System
11.1.1.5. Appetite Suppressors
11.1.2. Method of Deployment Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.1.2.1. Trans-oral
11.1.2.2. Endoscopy
11.1.2.3. Surgery
11.1.3. End User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.1.3.1. Hospitals
11.1.3.2. Gastroenterology clinics
11.1.3.3. Ambulatory surgical centers
11.1.4. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn),
Y-o-Y Growth (%), and Market Share (%)
11.1.4.1. Japan
11.1.4.2. China
11.1.4.3. India
11.1.4.4. ASEAN
11.1.4.5. Australia & New Zealand
11.1.4.6. Rest of Asia-Pacific
11.1.5. Asia-Pacific Anti-Obesity Devices Market- Opportunity Analysis Index - By Product Type, By Method of Deployment, By End User, and Country, 2017 – 2023
11.1.6. Asia-Pacific Anti-Obesity Devices Market Dynamics – Trends
12. LATIN AMERICA ANTI-OBESITY DEVICES MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
12.1.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1.1. Gastric Bands
12.1.1.2. Electrical Stimulation System
12.1.1.3. Gastric Balloon System
12.1.1.4. Gastric Emptying System
12.1.1.5. Appetite Suppressors
12.1.2. Method of Deployment Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.1.2.1. Trans-oral
12.1.2.2. Endoscopy
12.1.2.3. Surgery
12.1.3. End User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.1.3.1. Hospitals
12.1.3.2. Gastroenterology clinics
12.1.3.3. Ambulatory surgical centers
12.1.4. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.1.4.1. Brazil
12.1.4.2. Mexico
12.1.4.3. Argentina
12.1.4.4. Venezuela
12.1.4.5. Rest of Latin America
12.1.5. Latin America Anti-Obesity Devices Market- Opportunity Analysis Index - By Product Type, By Method of Deployment, By End User, and Country, 2017 – 2023
12.1.6. Latin America Anti-Obesity Devices Market Dynamics – Trends
13. MIDDLE EAST & AFRICA ANTI-OBESITY DEVICES MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
13.1.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1.1. Gastric Bands
13.1.1.2. Electrical Stimulation System
13.1.1.3. Gastric Balloon System
13.1.1.4. Gastric Emptying System
13.1.1.5. Appetite Suppressors
13.1.2. Method of Deployment Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.1.2.1. Trans-oral
13.1.2.2. Endoscopy
13.1.2.3. Surgery
13.1.3. End User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.1.3.1. Hospitals
13.1.3.2. Gastroenterology clinics
13.1.3.3. Ambulatory surgical centers
13.1.4. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.4.1. Gulf Cooperation Council (GCC) Countries
13.1.4.2. Israel
13.1.4.3. South Africa
13.1.4.4. Rest of MEA
13.1.5. MEA Anti-Obesity Devices Market- Opportunity Analysis Index - By Product Type, By Method of Deployment, By End User, and Country, 2017 – 2023
13.1.6. MEA Anti-Obesity Devices Market Dynamics – Trends
14. COMPETITION LANDSCAPE
14.1. Strategic Dashboard of Top Market Players
14.2. Company Profiles (Introduction, Financial Analysis, Product & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
14.2.1. Allergan, Inc. (U.S.)
14.2.2. Medtronic. (Covidien PLC) (U.S.)
14.2.3. EnteroMedics, Inc (U.S.)
14.2.4. Cousin Biotech (France)
14.2.5. Surgical IOC (Peters Surgical SAS) (France)
14.2.6. PARE Surgical Inc. (U.S.)
14.2.7. GI Dynamics (U.S.)
15. RESEARCH METHODOLOGY
16. KEY ASSUMPTIONS AND ACRONYMS
2. GLOBAL ANTI-OBESITY DEVICES MARKET INTRODUCTION
2.1. Global Anti-Obesity Devices Market– Taxonomy
2.2. Global Anti-Obesity Devices Market–Definitions
2.2.1. Product Type
2.2.2. End User
3. GLOBAL ANTI-OBESITY DEVICES MARKET DYNAMICS
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Anti-Obesity Devices Market Dynamics – Factors Impact Analysis
3.6. Global Anti-Obesity Devices Market– Regulations
3.6.1. U.S
3.6.2. Europe
3.6.3. Japan
3.7. Global Anti-Obesity Devices Market– Recent Product Launches
4. GLOBAL ANTI-OBESITY DEVICES MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023
4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Oppurtunity Analysis
5. GLOBAL ANTI-OBESITY DEVICES MARKET, BY PRODUCT TYPE, 2012 - 2016 AND FORECAST, 2017 - 2023
5.1. Gastric Bands
5.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Electrical Stimulation System
5.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Gastric Balloon System
5.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
5.4. Gastric Emptying System
5.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.3. Market Opportunity Analysis
5.5. Appetite Suppressors
5.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.5.3. Market Opportunity Analysis
6. GLOBAL ANTI-OBESITY DEVICES MARKET FORECAST, BY METHOD OF DEPLOYMENT, 2012 - 2016 AND FORECAST, 2017 - 2023
6.1. Trans-oral
6.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Endoscopy
6.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Surgery
6.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
7. GLOBAL ANTI-OBESITY DEVICES MARKET FORECAST, BY END USER, 2012 - 2016 AND FORECAST, 2017 - 2023
7.1. Hospitals
7.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Gastroenterology Clinics
7.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Ambulatory surgical centers
7.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
8. GLOBAL ANTI-OBESITY DEVICES MARKET FORECAST, BY REGION, 2012 - 2016 AND FORECAST, 2017 - 2023
8.1. North America
8.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Europe
8.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Asia-Pacific
8.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
8.4. Latin America
8.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.4.3. Market Opportunity Analysis
8.5. Middle East and Africa
8.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.5.3. Market Opportunity Analysis
8.6. Global Anti-Obesity Devices Market- Opportunity Analysis Index - By Product Type, By Method of Deployment, By End User, and Region, 2017 – 2023
9. NORTH AMERICA ANTI-OBESITY DEVICES MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
9.1.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
9.1.1.1. Gastric Bands
9.1.1.2. Electrical Stimulation System
9.1.1.3. Gastric Balloon System
9.1.1.4. Gastric Emptying System
9.1.1.5. Appetite Suppressors
9.1.2. Method of Deployment Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
9.1.2.1. Trans-oral
9.1.2.2. Endoscopy
9.1.2.3. Surgery
9.1.3. End User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
9.1.3.1. Hospitals
9.1.3.2. Gastroenterology clinics
9.1.3.3. Ambulatory surgical centers
9.1.4. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
9.1.4.1. U.S.
9.1.4.2. Canada
9.1.5. North America Anti-Obesity Devices Market- Opportunity Analysis Index - By Product Type, By Method of Deployment, By End User, and Country, 2017 – 2023
9.1.6. North America Anti-Obesity Devices Market Dynamics – Trends
10. EUROPE ANTI-OBESITY DEVICES MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
10.1.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1.1. Gastric Bands
10.1.1.2. Electrical Stimulation System
10.1.1.3. Gastric Balloon System
10.1.1.4. Gastric Emptying System
10.1.1.5. Appetite Suppressors
10.1.2. Method of Deployment Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.1.2.1. Trans-oral
10.1.2.2. Endoscopy
10.1.2.3. Surgery
10.1.3. End User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.1.3.1. Hospitals
10.1.3.2. Gastroenterology clinics
10.1.3.3. Ambulatory surgical centers
10.1.4. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.1.4.1. Germany
10.1.4.2. UK
10.1.4.3. France
10.1.4.4. Spain
10.1.4.5. Italy
10.1.4.6. Russia
10.1.4.7. Poland
10.1.4.8. Rest of Europe
10.1.5. Europe Anti-Obesity Devices Market- Opportunity Analysis Index - By Product Type, By Method of Deployment, By End User, and Country, 2017 – 2023
10.1.6. Europe Anti-Obesity Devices Market Dynamics – Trends
11. ASIA-PACIFIC ANTI-OBESITY DEVICES MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
11.1.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1.1. Gastric Bands
11.1.1.2. Electrical Stimulation System
11.1.1.3. Gastric Balloon System
11.1.1.4. Gastric Emptying System
11.1.1.5. Appetite Suppressors
11.1.2. Method of Deployment Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.1.2.1. Trans-oral
11.1.2.2. Endoscopy
11.1.2.3. Surgery
11.1.3. End User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.1.3.1. Hospitals
11.1.3.2. Gastroenterology clinics
11.1.3.3. Ambulatory surgical centers
11.1.4. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn),
Y-o-Y Growth (%), and Market Share (%)
11.1.4.1. Japan
11.1.4.2. China
11.1.4.3. India
11.1.4.4. ASEAN
11.1.4.5. Australia & New Zealand
11.1.4.6. Rest of Asia-Pacific
11.1.5. Asia-Pacific Anti-Obesity Devices Market- Opportunity Analysis Index - By Product Type, By Method of Deployment, By End User, and Country, 2017 – 2023
11.1.6. Asia-Pacific Anti-Obesity Devices Market Dynamics – Trends
12. LATIN AMERICA ANTI-OBESITY DEVICES MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
12.1.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1.1. Gastric Bands
12.1.1.2. Electrical Stimulation System
12.1.1.3. Gastric Balloon System
12.1.1.4. Gastric Emptying System
12.1.1.5. Appetite Suppressors
12.1.2. Method of Deployment Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.1.2.1. Trans-oral
12.1.2.2. Endoscopy
12.1.2.3. Surgery
12.1.3. End User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.1.3.1. Hospitals
12.1.3.2. Gastroenterology clinics
12.1.3.3. Ambulatory surgical centers
12.1.4. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.1.4.1. Brazil
12.1.4.2. Mexico
12.1.4.3. Argentina
12.1.4.4. Venezuela
12.1.4.5. Rest of Latin America
12.1.5. Latin America Anti-Obesity Devices Market- Opportunity Analysis Index - By Product Type, By Method of Deployment, By End User, and Country, 2017 – 2023
12.1.6. Latin America Anti-Obesity Devices Market Dynamics – Trends
13. MIDDLE EAST & AFRICA ANTI-OBESITY DEVICES MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
13.1.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1.1. Gastric Bands
13.1.1.2. Electrical Stimulation System
13.1.1.3. Gastric Balloon System
13.1.1.4. Gastric Emptying System
13.1.1.5. Appetite Suppressors
13.1.2. Method of Deployment Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.1.2.1. Trans-oral
13.1.2.2. Endoscopy
13.1.2.3. Surgery
13.1.3. End User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.1.3.1. Hospitals
13.1.3.2. Gastroenterology clinics
13.1.3.3. Ambulatory surgical centers
13.1.4. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.4.1. Gulf Cooperation Council (GCC) Countries
13.1.4.2. Israel
13.1.4.3. South Africa
13.1.4.4. Rest of MEA
13.1.5. MEA Anti-Obesity Devices Market- Opportunity Analysis Index - By Product Type, By Method of Deployment, By End User, and Country, 2017 – 2023
13.1.6. MEA Anti-Obesity Devices Market Dynamics – Trends
14. COMPETITION LANDSCAPE
14.1. Strategic Dashboard of Top Market Players
14.2. Company Profiles (Introduction, Financial Analysis, Product & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
14.2.1. Allergan, Inc. (U.S.)
14.2.2. Medtronic. (Covidien PLC) (U.S.)
14.2.3. EnteroMedics, Inc (U.S.)
14.2.4. Cousin Biotech (France)
14.2.5. Surgical IOC (Peters Surgical SAS) (France)
14.2.6. PARE Surgical Inc. (U.S.)
14.2.7. GI Dynamics (U.S.)
15. RESEARCH METHODOLOGY
16. KEY ASSUMPTIONS AND ACRONYMS